Solesence (SLSN) Liabilities and Shareholders Equity (2010 - 2026)

Solesence (SLSN) has 17 years of Liabilities and Shareholders Equity data on file, last reported at $47.8 million in Q1 2026.

• Quarterly Liabilities and Shareholders Equity fell 16.17% year-over-year to $47.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $211.8 million (up 8.1% YoY) and the FY2025 annual result came in at $50.1 million, changed 0.11% from the prior year.
• Liabilities and Shareholders Equity eased to $47.8 million in Q1 2026, from $50.1 million in the prior quarter.
• In the past five years, Liabilities and Shareholders Equity ranged from a high of $60.0 million in Q2 2025 to a low of $31.5 million in Q1 2023.
• A 5-year average of $41.9 million and a median of $38.5 million in 2024 frame the typical range for Liabilities and Shareholders Equity.
• Annual changes were most pronounced in 2022 — Liabilities and Shareholders Equity jumped 115.07% — and 2026, when it dropped 16.17%.
• Tracing SLSN's Liabilities and Shareholders Equity over 5 years: stood at $33.6 million in 2022, then fell by 2.02% to $32.9 million in 2023, then surged by 52.07% to $50.0 million in 2024, then increased by 0.11% to $50.1 million in 2025, then declined by 4.52% to $47.8 million in 2026.
• The last three Liabilities and Shareholders Equity figures came in at $47.8 million (Q1 2026), $50.1 million (Q4 2025), and $54.0 million (Q3 2025), per Business Quant data.